|
Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Sandoz |
|
|
Honoraria - Bristol-Myers Squibb |
Consulting or Advisory Role - Baxalta |
Speakers' Bureau - Alexion Pharmaceuticals; Bristol-Myers Squibb; Novartis |
Research Funding - Abbvie |
|
|
No Relationships to Disclose |
|
|
|
|
|
|
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Sandoz |
Speakers' Bureau - Amgen; Sandoz |